{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T02:13:52Z","timestamp":1788401632800,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007270","name":"University of Michigan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007270","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000926","name":"Wallace Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000926","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005630","name":"Wallace Foundation","doi-asserted-by":"publisher","award":["019850"],"award-info":[{"award-number":["019850"]}],"id":[{"id":"10.13039\/100005630","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-global.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology: Global"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jacig.2025.100620","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T23:48:11Z","timestamp":1764460091000},"page":"100620","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["COVID-19 mRNA revaccination is safe and well tolerated in individuals with previous adverse reactions to the vaccine and\/or long COVID"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5913-1222","authenticated-orcid":false,"given":"Ian F.","family":"Slack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly M.","family":"O\u2019Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George E.","family":"Freigeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea M.","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Jaafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"IV","given":"Charles F.","family":"Schuler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"James R.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacig.2025.100620_bib1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.15585\/mmwr.mm7002e1","article-title":"Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine\u2014United States, December 14-23, 2020","volume":"70","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jacig.2025.100620_bib2","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1016\/j.jaip.2021.06.006","article-title":"The risk of allergic reaction to SARS-CoV-2 vaccines and recommended evaluation and management: a systematic review, meta-analysis, GRADE assessment, and international consensus approach","volume":"9","author":"Greenhawt","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2025.100620_bib3","series-title":"Comirnaty (COVID-19 mRNA vaccine)","year":"2025"},{"key":"10.1016\/j.jacig.2025.100620_bib4","series-title":"SPIKEVAX (COVID-19 mRNA vaccine)","year":"2025"},{"key":"10.1016\/j.jacig.2025.100620_bib5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.puhe.2021.02.025","article-title":"Vaccine hesitancy in the era of COVID-19","volume":"194","author":"Troiano","year":"2021","journal-title":"Public Health"},{"key":"10.1016\/j.jacig.2025.100620_bib6","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.26882","article-title":"Trajectory of COVID-19 vaccine hesitancy over time and association of initial vaccine hesitancy with subsequent vaccination","volume":"4","author":"Siegler","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacig.2025.100620_bib7","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1056\/NEJMoa2110362","article-title":"Effectiveness of Covid-19 vaccines in ambulatory and inpatient care settings","volume":"385","author":"Thompson","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacig.2025.100620_bib8","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1056\/NEJMoa2115624","article-title":"BNT162b2 vaccine booster and mortality due to Covid-19","volume":"385","author":"Arbel","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacig.2025.100620_bib9","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0140-6736(21)02226-1","article-title":"Estimating the early impact of the US COVID-19 vaccination programme on COVID-19 cases, emergency department visits, hospital admissions, and deaths among adults aged 65 years and older: an ecological analysis of national surveillance data","volume":"399","author":"McNamara","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jacig.2025.100620_bib10","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1001\/jamainternmed.2022.4299","article-title":"COVID-19-associated hospitalizations among vaccinated and unvaccinated adults 18 years or older in 13 US states, January 2021 to April 2022","volume":"182","author":"Havers","year":"2022","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacig.2025.100620_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101624","article-title":"Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: a systematic review","volume":"53","author":"Notarte","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jacig.2025.100620_bib12","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.vaccine.2023.02.008","article-title":"Protective effect of COVID-19 vaccination against long COVID syndrome: a systematic review and meta-analysis","volume":"41","author":"Watanabe","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.jacig.2025.100620_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/bmjmed-2022-000385","article-title":"Effect of covid-19 vaccination on long covid: systematic review","volume":"2","author":"Byambasuren","year":"2023","journal-title":"BMJ Med"},{"key":"10.1016\/j.jacig.2025.100620_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-069676","article-title":"Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study","volume":"377","author":"Ayoubkhani","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.jacig.2025.100620_bib15","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2327663","article-title":"COVID-19 vaccination perspectives among patients with long COVID: a qualitative study","volume":"20","author":"MacEwan","year":"2024","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jacig.2025.100620_bib16","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.jaci.2021.12.789","article-title":"Updating the CoFAR Grading Scale for Systemic Allergic Reactions in food allergy","volume":"149","author":"Chinthrajah","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2025.100620_bib17","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1001\/jamainternmed.2021.3779","article-title":"Safety evaluation of the second dose of messenger RNA COVID-19 vaccines in patients with immediate reactions to the first dose","volume":"181","author":"Krantz","year":"2021","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacig.2025.100620_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2022.100654","article-title":"Second-dose COVID-19 vaccines are well tolerated in patients with allergic reactions to the first dose\u2014a single center experience","volume":"15","author":"Puxkandl","year":"2022","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jacig.2025.100620_bib19","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1016\/j.jaip.2021.05.010","article-title":"Safety of COVID-19 vaccination in patients with mastocytosis and monoclonal mast cell activation syndrome","volume":"9","author":"Kaakati","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2025.100620_bib20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/all.15476","article-title":"Outcomes of COVID-19 vaccination in 323 patients with clonal and non-clonal mast cell activation disorders","volume":"78","author":"Giannetti","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jacig.2025.100620_bib21","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jaci.2021.01.004","article-title":"mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis","volume":"147","author":"Rama","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2025.100620_bib22","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.jaip.2022.01.037","article-title":"COVID-19 vaccination in the setting of mastocytosis-Pfizer-BioNTech mRNA vaccine is safe and well tolerated","volume":"10","author":"Lazarinis","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2025.100620_bib23","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1016\/j.vaccine.2020.02.046","article-title":"Immunization stress-related response\u2014redefining immunization anxiety-related reaction as an adverse event following immunization","volume":"38","author":"Gold","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.jacig.2025.100620_bib24","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.jaci.2024.03.001","article-title":"A randomized double-blinded trial to assess recurrence of systemic allergic reactions following COVID-19 mRNA vaccination","volume":"153","author":"Khalid","year":"2024","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology: Global"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829325002218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829325002218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T04:34:52Z","timestamp":1773981292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772829325002218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2772829325002218"],"URL":"https:\/\/doi.org\/10.1016\/j.jacig.2025.100620","relation":{},"ISSN":["2772-8293"],"issn-type":[{"value":"2772-8293","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 mRNA revaccination is safe and well tolerated in individuals with previous adverse reactions to the vaccine and\/or long COVID","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology: Global","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacig.2025.100620","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}],"article-number":"100620"}}